HRP20050287A2 - Indole-3-carboxamides as glucokinase (gk) activators - Google Patents
Indole-3-carboxamides as glucokinase (gk) activatorsInfo
- Publication number
- HRP20050287A2 HRP20050287A2 HR20050287A HRP20050287A HRP20050287A2 HR P20050287 A2 HRP20050287 A2 HR P20050287A2 HR 20050287 A HR20050287 A HR 20050287A HR P20050287 A HRP20050287 A HR P20050287A HR P20050287 A2 HRP20050287 A2 HR P20050287A2
- Authority
- HR
- Croatia
- Prior art keywords
- glucokinase
- activators
- carboxamides
- indole
- diabetes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41573702P | 2002-10-03 | 2002-10-03 | |
| PCT/EP2003/010776 WO2004031179A1 (en) | 2002-10-03 | 2003-09-26 | Indole-3-carboxamides as glucokinase (gk) activators |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20050287A2 true HRP20050287A2 (en) | 2006-12-31 |
Family
ID=32069904
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20050287A HRP20050287A2 (en) | 2002-10-03 | 2005-03-24 | Indole-3-carboxamides as glucokinase (gk) activators |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US6881844B2 (xx) |
| EP (1) | EP1549638B1 (xx) |
| JP (1) | JP4390704B2 (xx) |
| KR (1) | KR100646486B1 (xx) |
| CN (1) | CN100348596C (xx) |
| AR (1) | AR041467A1 (xx) |
| AT (1) | ATE374768T1 (xx) |
| AU (1) | AU2003270285B2 (xx) |
| BR (1) | BR0315047A (xx) |
| CA (1) | CA2499329C (xx) |
| DE (1) | DE60316709T2 (xx) |
| DK (1) | DK1549638T3 (xx) |
| ES (1) | ES2293005T3 (xx) |
| HK (1) | HK1083098A1 (xx) |
| HR (1) | HRP20050287A2 (xx) |
| MX (1) | MXPA05003391A (xx) |
| MY (1) | MY136764A (xx) |
| NO (1) | NO20051103L (xx) |
| NZ (1) | NZ538466A (xx) |
| PA (1) | PA8584001A1 (xx) |
| PE (1) | PE20050090A1 (xx) |
| PL (1) | PL375149A1 (xx) |
| PT (1) | PT1549638E (xx) |
| RU (1) | RU2309956C2 (xx) |
| SI (1) | SI1549638T1 (xx) |
| TW (1) | TW200413364A (xx) |
| UY (1) | UY28005A1 (xx) |
| WO (1) | WO2004031179A1 (xx) |
| ZA (1) | ZA200502619B (xx) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0102299D0 (sv) | 2001-06-26 | 2001-06-26 | Astrazeneca Ab | Compounds |
| SE0102764D0 (sv) | 2001-08-17 | 2001-08-17 | Astrazeneca Ab | Compounds |
| WO2004050645A1 (en) * | 2002-10-03 | 2004-06-17 | Novartis Ag | Substituted (thiazol-2-yl) -amide or sulfonamide as glycokinase activators useful in the treatment of type 2 diabetes |
| GB0226931D0 (en) | 2002-11-19 | 2002-12-24 | Astrazeneca Ab | Chemical compounds |
| GB0226930D0 (en) * | 2002-11-19 | 2002-12-24 | Astrazeneca Ab | Chemical compounds |
| EP1532980A1 (en) * | 2003-11-24 | 2005-05-25 | Novo Nordisk A/S | N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes |
| CA2560689C (en) | 2004-04-02 | 2011-03-01 | Novartis Ag | Sulfonamide-thiazolpyridine derivatives as glucokinase activators useful in the treatment of type 2 diabetes |
| CA2561157A1 (en) | 2004-04-02 | 2005-10-13 | Novartis Ag | Thiazolopyridine derivatives, pharmaceutical conditions containing them and methods of treating glucokinase mediated conditions |
| WO2006112549A1 (ja) | 2005-04-20 | 2006-10-26 | Takeda Pharmaceutical Company Limited | 縮合複素環化合物 |
| US7622492B2 (en) | 2005-08-31 | 2009-11-24 | Hoffmann-La Roche Inc. | Pyrazolones as inhibitors of 11β-hydroxysteroid dehydrogenase |
| JP2007063225A (ja) | 2005-09-01 | 2007-03-15 | Takeda Chem Ind Ltd | イミダゾピリジン化合物 |
| KR20080048504A (ko) | 2005-09-29 | 2008-06-02 | 사노피-아벤티스 | 페닐- 및 피리디닐-1,2,4-옥사디아졸론 유도체, 이의제조방법 및 약제로서의 이의 용도 |
| CA2623958C (en) * | 2005-09-30 | 2013-05-28 | Banyu Pharmaceutical Co., Ltd. | 2-heteroaryl-substituted indole derivative |
| GT200600428A (es) * | 2005-09-30 | 2007-05-21 | Compuestos organicos | |
| GT200600429A (es) * | 2005-09-30 | 2007-04-30 | Compuestos organicos | |
| JP2009013065A (ja) * | 2005-10-14 | 2009-01-22 | Astellas Pharma Inc | 縮合へテロ環化合物 |
| EP1948614A2 (en) * | 2005-11-18 | 2008-07-30 | Takeda San Diego, Inc. | Glucokinase activators |
| US7351706B2 (en) * | 2006-01-05 | 2008-04-01 | Hoffmann-La Roche Inc. | Indol-3-yl-carbonyl-spiro-piperidine derivatives |
| US8034822B2 (en) | 2006-03-08 | 2011-10-11 | Takeda San Diego, Inc. | Glucokinase activators |
| EP1849785A1 (en) * | 2006-04-28 | 2007-10-31 | Neuropharma, S.A. | N-(2-Thiazolyl)-amide derivatives as GSK-3 inhibitors |
| PE20110235A1 (es) | 2006-05-04 | 2011-04-14 | Boehringer Ingelheim Int | Combinaciones farmaceuticas que comprenden linagliptina y metmorfina |
| WO2007143434A2 (en) * | 2006-05-31 | 2007-12-13 | Takeda San Diego, Inc. | Indazole and isoindole derivatives as glucokinase activating agents |
| EP2508524A3 (en) * | 2006-10-19 | 2012-10-24 | Takeda Pharmaceutical Company Limited | Indole compound |
| WO2008074694A1 (en) * | 2006-12-20 | 2008-06-26 | F. Hoffmann-La Roche Ag | Crystallization of glucokinase activators |
| JP5419706B2 (ja) | 2006-12-20 | 2014-02-19 | タケダ カリフォルニア インコーポレイテッド | グルコキナーゼアクチベーター |
| WO2008116107A2 (en) | 2007-03-21 | 2008-09-25 | Takeda San Diego, Inc. | Piperazine derivatives as glucokinase activators |
| NZ582056A (en) * | 2007-08-10 | 2012-08-31 | Lundbeck & Co As H | Bicyclic heteroaryl compounds for treating conditions related to p2x7 receptor activation |
| KR20110018366A (ko) * | 2008-05-16 | 2011-02-23 | 다케다 샌디에고, 인코포레이티드 | 글루코키나아제 활성제 |
| US8835644B2 (en) | 2009-03-20 | 2014-09-16 | University Of Virginia Patent Foundation | Broad spectrum benzothiophene-nitrothiazolide and other antimicrobials |
| JP2011006366A (ja) | 2009-06-26 | 2011-01-13 | Sanwa Kagaku Kenkyusho Co Ltd | 新規チオフェンカルボキサミド誘導体及びその医薬用途 |
| WO2012040170A2 (en) | 2010-09-20 | 2012-03-29 | University Of Virginia Patent Foundation | Compositions and methods for treating tuberculosis |
| CN103044310B (zh) * | 2013-01-18 | 2015-02-04 | 贵阳医学院 | 二氢吲哚-3-乙酸衍生物、其制备方法以及在药物中的应用 |
| WO2023067628A1 (en) * | 2021-10-20 | 2023-04-27 | Council Of Scientific And Industrial Research An Indian Registered Body Incorporated Under The Regn. Of Soc. Act (Act Xxi Of 1860) | A method for the preparation of indole-3-carboxylic acid derivatives |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2740686B1 (fr) | 1995-11-03 | 1998-01-16 | Sanofi Sa | Formulation pharmaceutique lyophilisee stable |
| US6262096B1 (en) | 1997-11-12 | 2001-07-17 | Bristol-Myers Squibb Company | Aminothiazole inhibitors of cyclin dependent kinases |
| US6040321A (en) | 1997-11-12 | 2000-03-21 | Bristol-Myers Squibb Company | Aminothiazole inhibitors of cyclin dependent kinases |
| JP5278983B2 (ja) | 1999-11-17 | 2013-09-04 | 塩野義製薬株式会社 | アミド化合物の新規用途 |
| PT1341774E (pt) | 2000-12-06 | 2006-05-31 | Hoffmann La Roche | Activadores heteroaromaticos, fundidos de glicocinase |
| US6433188B1 (en) | 2000-12-06 | 2002-08-13 | Wendy Lea Corbett | Fused heteroaromatic glucokinase activators |
| US6482951B2 (en) | 2000-12-13 | 2002-11-19 | Hoffmann-La Roche Inc. | Isoindolin-1-one glucokinase activators |
| IL156064A0 (en) | 2000-12-28 | 2003-12-23 | Daiichi Seiyaku Co | Vla-4 inhibitors |
| UA77303C2 (en) * | 2002-06-14 | 2006-11-15 | Pfizer | Derivatives of thienopyridines substituted by benzocondensed heteroarylamide useful as therapeutic agents, pharmaceutical compositions and methods for their use |
-
2003
- 2003-09-26 PT PT03750648T patent/PT1549638E/pt unknown
- 2003-09-26 RU RU2005113719/04A patent/RU2309956C2/ru not_active IP Right Cessation
- 2003-09-26 SI SI200331008T patent/SI1549638T1/sl unknown
- 2003-09-26 DE DE60316709T patent/DE60316709T2/de not_active Expired - Lifetime
- 2003-09-26 AU AU2003270285A patent/AU2003270285B2/en not_active Ceased
- 2003-09-26 DK DK03750648T patent/DK1549638T3/da active
- 2003-09-26 WO PCT/EP2003/010776 patent/WO2004031179A1/en active IP Right Grant
- 2003-09-26 JP JP2004540731A patent/JP4390704B2/ja not_active Expired - Fee Related
- 2003-09-26 KR KR1020057005669A patent/KR100646486B1/ko not_active IP Right Cessation
- 2003-09-26 BR BR0315047-0A patent/BR0315047A/pt not_active IP Right Cessation
- 2003-09-26 CA CA002499329A patent/CA2499329C/en not_active Expired - Fee Related
- 2003-09-26 AT AT03750648T patent/ATE374768T1/de not_active IP Right Cessation
- 2003-09-26 ES ES03750648T patent/ES2293005T3/es not_active Expired - Lifetime
- 2003-09-26 NZ NZ538466A patent/NZ538466A/en unknown
- 2003-09-26 PL PL03375149A patent/PL375149A1/xx not_active Application Discontinuation
- 2003-09-26 MX MXPA05003391A patent/MXPA05003391A/es active IP Right Grant
- 2003-09-26 CN CNB038236796A patent/CN100348596C/zh not_active Expired - Fee Related
- 2003-09-26 EP EP03750648A patent/EP1549638B1/en not_active Expired - Lifetime
- 2003-09-30 US US10/674,481 patent/US6881844B2/en not_active Expired - Fee Related
- 2003-09-30 PE PE2003000988A patent/PE20050090A1/es not_active Application Discontinuation
- 2003-09-30 PA PA20038584001A patent/PA8584001A1/es unknown
- 2003-09-30 TW TW092127030A patent/TW200413364A/zh unknown
- 2003-10-01 UY UY28005A patent/UY28005A1/es not_active Application Discontinuation
- 2003-10-01 AR ARP030103589A patent/AR041467A1/es unknown
- 2003-10-01 MY MYPI20033742A patent/MY136764A/en unknown
-
2005
- 2005-03-01 NO NO20051103A patent/NO20051103L/no not_active Application Discontinuation
- 2005-03-24 HR HR20050287A patent/HRP20050287A2/xx not_active Application Discontinuation
-
2006
- 2006-01-19 ZA ZA200502619A patent/ZA200502619B/en unknown
- 2006-04-10 HK HK06104334A patent/HK1083098A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20050287A2 (en) | Indole-3-carboxamides as glucokinase (gk) activators | |
| RS93604A (xx) | Supstituisani fenilacetamidi i njihova primena kao aktivatori glukokinaze | |
| MA26973A1 (fr) | Activateurs glucokinase isoindolin-1-one | |
| MY136926A (en) | Glucokinase activators | |
| ATE381539T1 (de) | Dipeptidylpeptidase-hemmer zur behandlung von diabetes | |
| GB0209891D0 (en) | Novel compounds | |
| MY145590A (en) | Phenylacetamides and their use as glucokinase modulators | |
| DK1864975T3 (da) | Nikotinamid-derivater anvendelige som P38-inhibitorer | |
| NO20076658L (no) | Heteroarylbenzamidderivater for anvendelse som GLK aktivatorer ved behandling av diabetes | |
| EA200101166A1 (ru) | Ингибиторы металлопротеаз | |
| EA200600203A1 (ru) | Производные 2-(хиноксалин-5-илсульфониламино)бензамида в качестве модуляторов сск2 | |
| NO20063576L (no) | 1,3-dioksanederivativer og analoge forbindelser for behandling av fedme og diabetes | |
| MXPA05011962A (es) | Oxiarenos substituidos. | |
| MX2008001778A (es) | Combinacion de un agente hipnotico y un compuesto de bis arilo y heteroarilo sustituido y aplicacion terapeutica de la misma. | |
| TW200407133A (en) | Novel PPARα and PPARγ agonists | |
| TW200609228A (en) | Substituted n-acyl-2-aminothiazoles | |
| ATE449066T1 (de) | Biguanidderivate | |
| ATE458482T1 (de) | Verwendung von amino substituierten benzimidazolen | |
| NO20033413D0 (no) | Krystallmodifisering av et syklisk depsipeptid med forbedret aktivitet | |
| MY140194A (en) | Novel fusidic acid derivatives | |
| TW200514780A (en) | Tri(cyclo)substituted amide glucokinase activator compounds | |
| SG145571A1 (en) | Intermediates useful in the synthesis of hiv-protease inhibitors and methods for preparing the same | |
| TW200510447A (en) | Novel fusidic acid derivatives | |
| JO2238B1 (en) | Glycine stimulants iswindline 1- on |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A1OB | Publication of a patent application | ||
| ARAI | Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application | ||
| ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20080822 Year of fee payment: 6 |
|
| OBST | Application withdrawn |